Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 85,184 shares at $0.70 ($58K) on 2022-08-02, disclosed to the SEC on 2022-08-03.
Scheduled sale ($58k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.67 | 56,432 | $38K | 65.3% |
| 2 | $0.70 | 28,752 | $20K | 34.7% |
| Total | $0.68 avg | 85,184 | $58K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |